1. Home
  2. SGD vs SCNI Comparison

SGD vs SCNI Comparison

Compare SGD & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGD
  • SCNI
  • Stock Information
  • Founded
  • SGD 2021
  • SCNI 2003
  • Country
  • SGD United States
  • SCNI Israel
  • Employees
  • SGD N/A
  • SCNI N/A
  • Industry
  • SGD
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SGD
  • SCNI Health Care
  • Exchange
  • SGD Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • SGD 1.8M
  • SCNI 2.3M
  • IPO Year
  • SGD N/A
  • SCNI N/A
  • Fundamental
  • Price
  • SGD $0.86
  • SCNI $2.30
  • Analyst Decision
  • SGD
  • SCNI
  • Analyst Count
  • SGD 0
  • SCNI 0
  • Target Price
  • SGD N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • SGD 57.5K
  • SCNI 94.8K
  • Earning Date
  • SGD 08-22-2025
  • SCNI 08-14-2025
  • Dividend Yield
  • SGD N/A
  • SCNI N/A
  • EPS Growth
  • SGD N/A
  • SCNI N/A
  • EPS
  • SGD N/A
  • SCNI N/A
  • Revenue
  • SGD $175,906.00
  • SCNI $658,000.00
  • Revenue This Year
  • SGD N/A
  • SCNI N/A
  • Revenue Next Year
  • SGD N/A
  • SCNI N/A
  • P/E Ratio
  • SGD N/A
  • SCNI N/A
  • Revenue Growth
  • SGD 253.11
  • SCNI N/A
  • 52 Week Low
  • SGD $0.65
  • SCNI $1.90
  • 52 Week High
  • SGD $9.98
  • SCNI $8.92
  • Technical
  • Relative Strength Index (RSI)
  • SGD 45.77
  • SCNI 47.02
  • Support Level
  • SGD $0.75
  • SCNI $2.06
  • Resistance Level
  • SGD $0.89
  • SCNI $2.50
  • Average True Range (ATR)
  • SGD 0.07
  • SCNI 0.24
  • MACD
  • SGD 0.00
  • SCNI 0.01
  • Stochastic Oscillator
  • SGD 38.33
  • SCNI 30.38

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: